GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 21.30
+0.05 (0.24%)
Jul 18, 2025, 1:35 PM CST
TPE:3164 Revenue
GenMont Biotech Incorporation had revenue of 99.45M TWD in the quarter ending March 31, 2025, a decrease of -14.57%. This brings the company's revenue in the last twelve months to 368.41M, up 3.83% year-over-year. In the year 2024, GenMont Biotech Incorporation had annual revenue of 385.37M with 21.18% growth.
Revenue (ttm)
368.41M
Revenue Growth
+3.83%
P/S Ratio
4.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 385.37M | 67.36M | 21.18% |
| Dec 31, 2023 | 318.02M | -50.53M | -13.71% |
| Dec 31, 2022 | 368.55M | -59.38M | -13.88% |
| Dec 31, 2021 | 427.93M | 102.74M | 31.59% |
| Dec 31, 2020 | 325.19M | -21.05M | -6.08% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| TaiMed Biologics | 607.46M |